Dupixent (dupilumab) - Sanofi, Regeneron
Early Dupilumab Treatment for Pediatric Eosinophilic Esophagitis Is Associated with Reduced Incident Asthma (ACAAI 2026) - Oct 28, 2026 - Abstract #R052; Pres time: Nov 13, 2026; 04:05 PM - 06:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 15; No abstract available 
Clinical • Asthma • Eosinophilic Esophagitis • Gastrointestinal Disorder • Immunology • Pediatrics • Respiratory Diseases
https://annualmeeting.acaai.org/2026/submit_abstract.cfm
 
Oct 28, 2026
 
Prev Next